Literature DB >> 6136042

The Florey lecture, 1983. Biological control, as exemplified by smallpox eradication and myxomatosis.

F Fenner.   

Abstract

Biological control is an important method of dealing with plant and insect pests. The control of rabbits by myxomatosis and the eradication of smallpox by vaccination are unusual examples of biological control, in that they involve a vertebrate and a viral pest respectively. Myxomatosis is a benign disease in Sylvilagus rabbits in South America which is transmitted mechanically by mosquitoes. In the European rabbit, Oryctolagus, which is a pest in Australia and England, the virus from Sylvilagus produces a generalized disease that is almost always lethal. Myxomatosis was deliberately introduced into Australia in 1950 and into Europe in 1952. It was at first spectacularly successful in controlling the rabbit pest, but biological adjustments occurred in the virulence of the virus and the genetic resistances of rabbits. After 30 years of interaction, natural selection has resulted in a balance at a fairly high level of viral virulence. Smallpox has been a major scourge of mankind for over 1500 years. It spread from Asia to Europe in the Middle ages and from Europe to Africa and the Americas in the 15th and 16th centuries. Jenner's cowpox vaccine provided a method of control that reduced the severity of the disease during the 19th century but failed to eliminate the disease from many countries before the 1930s. Thereafter it was eradicated from Europe and North America, but remained endemic in South America, Africa and Asia. In 1967 it was still endemic in 33 countries and W.H.O. established a programme for global eradication within 10 years. The goal was achieved in 1977. Problems of the eradication programme and reasons for its success will be described.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136042     DOI: 10.1098/rspb.1983.0039

Source DB:  PubMed          Journal:  Proc R Soc Lond B Biol Sci        ISSN: 0950-1193


  33 in total

1.  Evolution of parasite virulence against qualitative or quantitative host resistance.

Authors:  S Gandon; Y Michalakis
Journal:  Proc Biol Sci       Date:  2000-05-22       Impact factor: 5.349

Review 2.  Syphilis in renaissance Europe: rapid evolution of an introduced sexually transmitted disease?

Authors:  Robert J Knell
Journal:  Proc Biol Sci       Date:  2004-05-07       Impact factor: 5.349

Review 3.  Immunological memory ≠ protective immunity.

Authors:  Rolf M Zinkernagel
Journal:  Cell Mol Life Sci       Date:  2012-04-06       Impact factor: 9.261

Review 4.  Minding the gap: The impact of B-cell tolerance on the microbial antibody repertoire.

Authors:  Joel Finney; Akiko Watanabe; Garnett Kelsoe; Masayuki Kuraoka
Journal:  Immunol Rev       Date:  2019-09-27       Impact factor: 12.988

Review 5.  Evolutionary medicine: its scope, interest and potential.

Authors:  Stephen C Stearns
Journal:  Proc Biol Sci       Date:  2012-08-29       Impact factor: 5.349

6.  Next step in the ongoing arms race between myxoma virus and wild rabbits in Australia is a novel disease phenotype.

Authors:  Peter J Kerr; Isabella M Cattadori; June Liu; Derek G Sim; Jeff W Dodds; Jason W Brooks; Mary J Kennett; Edward C Holmes; Andrew F Read
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

7.  Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma.

Authors:  Bingtao Tang; Zong Sheng Guo; David L Bartlett; David Z Yan; Claire P Schane; Diana L Thomas; Jia Liu; Grant McFadden; Joanna L Shisler; Edward J Roy
Journal:  Clin Cancer Res       Date:  2020-02-04       Impact factor: 12.531

8.  Evolution of natural populations in the Drosophila melanogaster sigma virus system I. Languedoc (southern France).

Authors:  A Fleuriet; G Periquet; D Anxolabéhère
Journal:  Genetica       Date:  1990       Impact factor: 1.082

9.  Evolution of acute infections and the invasion-persistence trade-off.

Authors:  Aaron A King; Sourya Shrestha; Eric T Harvill; Ottar N Bjørnstad
Journal:  Am Nat       Date:  2009-04       Impact factor: 3.926

Review 10.  Virulence evolution in response to vaccination: the case of malaria.

Authors:  M J Mackinnon; S Gandon; A F Read
Journal:  Vaccine       Date:  2008-07-18       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.